Public Company News

Kazia Therapeutics Announces $2 Million Private Placement at Premium to Market

SYDNEY, Aug. 1, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced that it has entered into a securities purchase agreement with certain established institutional investors for a private placement of equity securities (PIP...

2025-08-01 20:00 5357

XCMG Elevates Global Aftermarket Service Capabilities with Inaugural World Skills Competition

XUZHOU, China, Aug. 1, 2025 /PRNewswire/ -- XCMG Machinery (SHE:000425), a global leader in construction machinery, has successfully concluded its first-ever XCMG World Skills Competition, marking a strategic leap in enhancing worldwide aftermarket service capabilities. The event underscores XCMG...

2025-08-01 19:56 3859

Huya Celebrates Success with Inaugural Delta Force Diamond Champions Summer Season Tournament

GUANGZHOU, China, Aug. 1, 2025 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game-related entertainment and services provider, recently successfully concluded its inaugural Delta Force Diamond Champions (DDC) Summer Season, demonstrating Huya's continued commitment t...

2025-08-01 18:45 2923

Johnson Controls Completes Sale of Residential and Light Commercial HVAC Business

* Transaction accelerates the company's transformation as a pure-play provider of innovative building solutions CORK, Ireland, Aug. 1, 2025 /PRNewswire/ -- Johnson Controls International plc (NYSE: JCI), a global leader for smart, safe, healthy and sustainable buildings, today announced it has ...

2025-08-01 18:00 4033

Energenesis Biomedical Announces Positive Phase I Results for ENERGI-F705PD, a Potential Disease-Modifying Treatment for Parkinson's Disease

* The Phase I trial of ENERGI-F705PD tablet was a randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and pharmacokinetics of the investigational drug in 24 healthy subjects. * The results confirmed the favorable safety and tolerability profile of ...

2025-08-01 15:52 2533

Zeekr Group Announces July 2025 Delivery Update

HANGZHOU, China, Aug. 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced its delivery results forJuly 2025. In July, Zeekr Group delivered a total of 44,193 vehicl...

2025-08-01 15:30 2498

OpenTable Launches Gen-Al Powered Concierge to Arm Diners with Instant Insights for its 60,000+ Global Restaurants

New Feature Powers Dining Discovery, Bringing Restaurant Research Into the Booking Process SYDNEY, Aug. 1, 2025 /PRNewswire/ -- OpenTable, a global leader in restaurant tech, has debuted 'Concierge ', a generative Al-powered as...

2025-08-01 13:17 2703

GenScript Biotech's MSCI ESG Rating Upgraded to AA, Recognized as a Global Leader

PISCATAWAY, N.J., July 31, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a leading global provider of life science research and manufacturing services, today announced that its ESG rating has been upgraded to AA from A by MSCI in recognition of the company's excellence in the area...

2025-08-01 10:02 2352

Medit to Reveal New Medit i900 Mobility, Powered by True Mobility

SEOUL, South Korea, Aug. 1, 2025 /PRNewswire/ -- Medit (www.medit.com ), a global leader in digital dentistry, today introduces theMedit i900 Mobility, a next-generation intraoral scanner designed to deliver simplicity and true mobility to clinical workflows.

2025-08-01 08:00 3830

OSR Holdings Provides Transparency Update on Equity Financing Instruments

BELLEVUE, Wash., July 31, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical innovation approaches to health and wellness to support global health outcomes, today provided a transparency update regarding its Equity Line of Credit (ELOC) agreem...

2025-08-01 00:45 5518

Keysight Receives Frost & Sullivan's 2025 Global Company of the Year Award for Excellence in 6G Test and Measurement

Recognition underscores Keysight's market leadership, customer-centric innovation, and pioneering role in accelerating 6G technology validation through AI, digital twin testing, and spectrum exploration SAN ANTONIO, July 31, 2025 /PRNewswire/ -- Frost & Sullivan is proud to recognizeKeysight Tec...

2025-07-31 23:00 2510

S4Capital's Monks Appoints Danny Lee as Managing Director for Greater China

SHANGHAI, July 31, 2025 /PRNewswire/ -- Monks, the global, purely digital, data-driven, unitary operating brand of S4Capital plc, is proud to announce the appointment ofDanny Lee as Managing Director, Monks Greater China, effective immediately.

2025-07-31 22:44 3038

e& reports 60.7% increase in consolidated net profit, reaching AED 8.8 billion in H1 2025

* Q2 consolidated revenue increased to AED 18.0 billion, a 28.1% year-on-year growth * Q2 consolidated net profit rises to AED 3.5 billion, backed by 9.7% year-on-year growth * Q2 EBITDA reached AED 8.0 billion at a margin of 44.5%, an increase of 22.2% year-on-year ABU DHABI, UAE, July 31,...

2025-07-31 22:41 3539

Supermicro Open Storage Summit Showcases the Impact of AI Workloads on Storage: Starts August 12

* Expanded virtual event features 9 sessions, 23 companies and 40 speakers, up from 7 sessions in 2024 * Focused on AI workloads including distributed inference infrastructure models, enterprise AI using Agentic, RAG, and GenAI and their impact on storage * Other topics include Storage-as-a-...

2025-07-31 21:05 3468

Cyient, Zinier Announce Strategic Partnership to Accelerate Field Service Transformation

HYDERABAD, India, July 31, 2025 /PRNewswire/ -- Cyient Limited, a global Intelligent Engineering solutions company, and Zinier, a leading provider of AI-powered Field Service Management (FSM) software, have announced a strategic go-to-market partnership to deliver rapid, scalable field service t...

2025-07-31 21:00 2409

Neurophet Showcases Full-Cycle Brain Imaging Analysis Solutions for Alzheimer's disease Including 'Neurophet AQUA AD' at AAIC 2025

* Showcased brain imaging analysis products such as Neurophet AQUA AD, capable of monitoring side effects of Alzheimer's disease treatments * Engaged in partnering with global big pharma and neurology KOLs, seeking global development collaborations for key products SEOUL, South Korea, July 31,...

2025-07-31 21:00 2723

NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO

NEW YORK, July 31, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-market update + Figma valued at over ...

2025-07-31 20:57 3874

Pop Culture Group's Investment Project "Huaya Times" Officially Launches in Xiamen

XIAMEN, China, July 31, 2025 /PRNewswire/ -- Huaya Times (华雅•时代), a project invested by Pop Culture Group Co., Ltd. (Nasdaq: CPOP), officially launched on July 24, 2025. The project introduces a new residential product, "Huaya Times," by Budian Home, presenting a groundbreaking solution for the mo...

2025-07-31 20:45 3219

Autohome Inc. Announces 2025 Q2 Earnings: AI-Driven Product Upgrades and Breakthroughs in Global Expansion

HONG KONG, July 31, 2025 /PRNewswire/ -- Autohome Inc. (NYSE: ATHM; HKEX: 2518) ("Autohome" or the "Company"), the leading online destination for automobile consumers inChina, today announced its financial results for the second quarter of 2025. The Company reported total revenue ofRMB1,758.1 mil...

2025-07-31 19:44 3942

Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Received U.S. FDA IND Approval to Initiate a Phase II Clinical Study for Platinum-Resistant Ovarian Cancer

SUZHOU, China, July 31, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has received approval from the U.S. Food and Drug Administration (FDA) to initiate a Phase II clinical study inthe United States (study n...

2025-07-31 18:36 3039